Pharmaceuticals

FDA approves Lilly’s Xanla to treat early symptoms of Alzheimer’s disease

bexib
By bexib 0 Min Read

According to the company, Xanra is the first amyloid plaque-targeted therapy that allows treatment to be discontinued once plaque is removed.

You Might Also Like

Closed Loop and Farmanovia explore combination of precision medicine in hypertension

LucyTx Announces Additional $12.5 Million in Funding for Neurological Disease Research

Future-proof your consulting career into 2024 and beyond

Pharma Pulse 7/1/24: AI craze sends stocks soaring in H1, considerations for integrating artificial intelligence and more

IMF Chief Medical Officer Talks Iceland’s First Bike Trip and Blood Cancer Awareness

Share This Article
Previous Article UniCredit Bank’s Schulze speaks at Bank Automation Summit Europe 2024
Next Article Hack Club! Launches Foundation to Support Thousands of Teen Creators Around the World
Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

5 fintech trends that will shake up Singapore in 2025
Fintech
Indonesia’s OJK issues new regulations on alternative credit scoring
Fintech
Donald Trump signs executive orders on trade on his first day in office
Manufacturing
Fifth Third expands branch network and doubles technology capabilities
Banking